The present invention aims to provide a prophylactic and/or therapeutic agent for scleroderma. The present invention also aims to provide a Th2 promotion inhibitor or a vascular stabilizing agent. Glycyrrhetinic acids and/or salts thereof are applied for prevention of scleroderma, treatment of scleroderma, inhibition of Th2 promotion, or stabilization of blood vessels.